250 Ces Urol 2023; 27(3): 243-250 PŘEHLEDOVÉ ČLÁNKY LITERATURA 1. Šrámková T. Mužské stárnutí z pohledu sexuologa. 1. vydání, Praha: Grada‑Publishing, a. s., 2023; 200 s. ISBN 978-80-271-3525-7. 2. Weiss P, Zvěřina J. Sexuální chování české populace. Urol praxi. 2009; 10(3): 160–163. 3. Meisner A, Mamoulakis Ch, Veldink GJ. Sexual problems in patients with cancer. In: Olver N. (ed). The MASCC Textbook of Cancer Supportive Care nad Survivorship. Springer US. 2011; 127–132. 4. Schover LR. Sexuality. In. Foxhall LE, Rodriguez MA (eds). Advances in Cancer Survivorship Management. New York: Springer. 2015; 401–412. 5. Chung E, Gillman M. Prostate cancer survivor ship: a review of erectile dysfunction and penile rehabi‑ litation after prostate cancer. Med J Aust. 2014; 200(10): 582–585. 6. Rasmusson E, Gunnlaugsson A, Wieslander E. Erectile dysfunction and absorbed dose to penile base structures in a randomized trial comparing ultrahypofractionated and conventionally fractionated radiation therapy for prostate cancer. Int J Radiat Oncol Biol Phys. 2020; 107(1): 143–151. 7. Bessa A, Martin R, Haggstrom Ch, et al. Unmet needs in sexual health in bladder cancer patients: a systematic review of the evidence. BMC Urology. 2020; 3(20):64. 8. Sterk P, Shekarriz B, Grunter S. Voiding and sexual dysfunction after deep rectal resection and total mesorectal excision. Prospective study of 52 patients. Int J Colorectal, DiS. 2005; 20(5): 423–427. 9. Montorsi F, Brock G, Stolzenburg JU, et al. Effects of tadalafil treatment on erectile function recovery following bilateral nerve‑sparing radical prostatectomy: a randomised placebo controlled study (REACTT). Eur Urol. 2014; 65(3): 587–596. 10. Salonia A, Bettocchi C, Carvalho J, et al. EAU Guidelines on Sexual and Reproductive Health [online]. Available from: EAU‑Guidelines‑on‑Sexual‑and‑Reproductive‑Health-2023.pdf (d56bochluxqnz.cloudfront.net). 11. Baccaglini W, Pazeto CL, Correa Barros EA, et al. The role of the low‑intensity extracorporeal shoc‑ kwave therapy on penile rehabilitation after radical prostatectomy: a randomized clinical trial. J Sex Med. 2020; 17(4): 688–694. 12. Rosen RC, Riley A, Wagner G, et al. The International Index of Eectile Function (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology. 1997; 49(6): 822–830. 13. Mykoniatis I, Pyrgidis N, Sokolakis J, et al. Assessment of combination therapies vs monotherapy for erectile dysfunction: a systematic review and meta‑analysis. JAMA Netw Open. 2021; 4(2): e2036337. 14. Cui H, Liu B, Song Z, et al. Efficacy and safety of long‑term tadalafil 5 mg once daily combined with sildenafil 50 mg as needed at the early stage of treatment for patients with erectile dysfunction. Andro‑ logia. 2015; 47(1): 20-24. 15. Anaissie J, Hellstrom WJG. Clinical use of alprostadil topical cream in patiens with erectile dysfunction: a review. Res Rep Urol. 2016; 3(8): 123–131. 16. Chuang FP, Lakin M, Wu ST, et al. Experience with intracavernous injection in the treatment of erectile dysfunction after radical prostatectomy dose considerations. Int J Imp Res. 2011; 23(4): 146–150. 17. Kratochvíl S. Sexuální dysfunkce, 3. vyd. Praha: Grada‑Publishing, a. s. 2008; 304 s. 18. Choi E, Buie J, Camacho J, et al. Evolution of androgen deprivation therapy (ADT) and its new emer‑ ging modalities in prostate cancer: an update for practicing urologists, clinicians and medical providers. Res Rep Urol. 2022; 14: 87–108. 19. Collins L, Basaria S. Adverse effects of androgen deprivation therapy in men with prostate cancer: a focus on metabolic and cardiovascular complications. Asian J Androl. 2012; 14(2): 222–225. 20. Fryšák Z, Karásek D, Halenka M. Hypogonadismus mužů – příčiny, diagnostika, léčba. Urol praxi. 2010; 11(2): 75–77. 21. Stárka L. Mužský hypogonadismus a civilizační onemocnění. Čas Lék Čes. 2012; 151(2): 69–72.
RkJQdWJsaXNoZXIy NDA4Mjc=